Searched for: subject%3A%22Mild%255C%2Bcognitive%255C%2Bimpairment%22
(1 - 3 of 3)
Meiland, F.J.M. (author), Hattink, B.J.J. (author), Overmars-Marx, T. (author), de Boer, M.E. (author), Jedlitschka, A. (author), Ebben, P.W.G. (author), Stalpers-Croeze, I.I.N.W. (author), Flick, S. (author), van der Leeuw, J. (author), Karkowski, I.P. (author), Dröes, R.M. (author)
Background: In the European Rosetta project three separate, previously developed, ICT systems were improved and integrated to create one modular system that helps community-dwelling people with mild cognitive impairment and dementia in different stages of the disease. The system aims to support them in daily functioning, monitor (deviations from...
article 2014
Mulder, S.D. (author), van der Flier, W.M. (author), Verheijen, J.H. (author), Mulder, C. (author), Scheltens, P. (author), Blankenstein, M.A. (author), Hack, C.E. (author), Veerhuis, R. (author), TNO Kwaliteit van Leven (author)
Several studies have shown that reduced amyloid-β 1-42 (Aβ {42}) and increased tau levels in cerebrospinal fluid (CSF) reflect increased Alzheimer's disease (AD) pathology in the brain. β-site APP cleaving enzyme (BACE1) is thought to be the major β-secretase involved in Aβ production in the brain, and therefore we investigated the relation...
article 2010
van Uffelen, J.G.Z. (author), Chin A Paw, M.J.M. (author), Klein, M. (author), van Mechelen, W. (author), Hopman-Rock, M. (author), TNO Kwaliteit van Leven (author)
Background: Development of efficient methods for identifying subjects with Mild Cognitive Impairment (MCI) from the geneneral population is warranted, because these subjects represent an important group for (epidemiological) research purposes. Objectives: (1) To describe a two-step population screening for identifying adults with MCI from the...
article 2007